Results 221 to 230 of about 19,414 (233)

Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study

Lancet Oncology, The, 2017
Francesco Passamonti, Martin Griesshammer, Francesca Palandri   +2 more
exaly  

Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

Journal of Clinical Oncology, 2005
Roberto Marchioli, Raffaele Landolfi, Heinz Gisslinger   +2 more
exaly  

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Nature Medicine, 2013
Carla Casu, Sara Gardenghi, Laura Breda
exaly  

Twelve-Year Remission of Polycythemia Vera Following Hodgkin's Disease and Chemotherapy

Ca-A Cancer Journal for Clinicians, 1981
exaly  

Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera

Cancer Cell, 2008
Gerlinde Wernig, Michael G Kharas
exaly  

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

New England Journal of Medicine, 2013
Heinz Gisslinger, Ashot S Harutyunyan, Harini Nivarthi   +2 more
exaly  

Characterization of alkali treated and untreated new cellulosic fiber from Saharan aloe vera cactus leaves

Carbohydrate Polymers, 2017
Balaji A N, Nagarajan K J
exaly  

Aloe vera gel: update for dentistry.

General dentistry, 2005
openaire   +1 more source

Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders

Nature Reviews Cancer, 2007
exaly  

Aloe Vera Gel Effective for Oral Lichen Planus

Journal of the National Medical Association, 2008
openaire   +1 more source